Familial Colorectal Cancer Type X: The Other Half of Hereditary Nonpolyposis Colon Cancer Syndrome

Surgical Oncology Clinics of North America

Volumn 18, Issue 4, 2009, Pages 637-645

  Lindor, Noralane M ^a  

^a MAYO CLINIC   (United States)

Author keywords

Cancer; Colorectal; Familial; Hereditary; HNPCC; Nonpolyposis

Indexed keywords

APC PROTEIN; B RAF KINASE; K RAS PROTEIN; MESSENGER RNA; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6; PROTEIN P53; TRANSCRIPTION FACTOR CDX2;

AUTOSOMAL DOMINANT INHERITANCE; CANCER INCIDENCE; CANCER RISK; CANCER SUSCEPTIBILITY; COLON CARCINOGENESIS; COLORECTAL CANCER; DNA DETERMINATION; ENDOMETRIUM CANCER; FAMILIAL CANCER; GENE MUTATION; GENETIC PREDISPOSITION; GENETIC SCREENING; HEREDITARY NONPOLYPOSIS COLON CANCER SYNDROME; HIGH RISK POPULATION; HUMAN; MISMATCH REPAIR; MUTATIONAL ANALYSIS; PRACTICE GUIDELINE; REVIEW;

COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA MISMATCH REPAIR; HUMANS; NEOPLASM PROTEINS; SYNDROME;

EID: 70349316522     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soc.2009.07.003     Document Type: Review

References (22)

1. Warthin A. Heredity with reference to carcinoma as shown by the study of the cases examined in the pathological laboratory of the University of Michigan 1895-1913. Arch Intern Med 12 (1913) 546-555
2. Merg A., Lynch H., Lynch J., et al. Hereditary colorectal cancer-part II. Curr Probl Surg 42 5 (2005) 267-333
3. Lynch H., Shaw M., Magnuseo C., et al. Hereditary factors in cancer: study of two large midwestern kindreds. Arch Intern Med 117 (1966) 206-212
4. Vasen H., Mecklin J., Khan P., et al. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 334 5 (1991) 424-425
5. Burke W., Petersen G., Lynch P., et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. Cancer Genetics Studies Consortium. JAMA 277 11 (1997) 915-919
6. Vasen H., Watson P., Mecklin J., et al. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 116 6 (1999) 1453-1456
7. Bisgaard M., Jager A., Myrhoj T., et al. Hereditary non-polyposis colorectal cancer (HNPCC): phenotype-genotype correlation between patients with and without identified mutation. Hum Mutat 20 (2002) 20-27
8. Wijnen J., Vasen H., Kahn M., et al. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer. N Engl J Med 339 (1998) 511-518
9. Lindor N., Rabe K., Petersen G., et al. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA 293 16 (2005) 1979-1985
10. Jass J. Hereditary non-polyposis colorectal cancer: the rise and fall of a confusing term. World J Gastroenterol 12 3 (2006) 4943-4950
11. Renkonen E., Zhang Y., Lohi H., et al. Altered expression of MLH1, MSH2, and MSH6 in predisposition to hereditary nonpolyposis colorectal cancer. J Clin Oncol 21 19 (2003) 3629-3637
12. Schiemann U., Muller-Koch Y., Gross M., et al. Extended microsatellite analysis in microsatellite stable, MSH2 and MLH1 mutation-negative HNPCC patients: genetic reclassification and correlation with clinical features. Digestion 69 (2004) 166-176
13. Abdel-Rahman W., Ollikainen M., Kariola R., et al. Comprehensive characterization of HNPCC-related colorectal cancers reveals striking molecular features in families with no germline mismatch repair gene mutations. Oncogene 24 9 (2005) 1542-1551
14. Sanchez-de-Abajo A., de la Hoya M., van Puijenbroek M., et al. Molecular analysis of colorectal cancer tumors in patients with mismatch repair-proficient hereditary nonpolyposis colorectal cancer suggests novel carcinogenic pathways. Clin Cancer Res 13 19 (2007) 5729-5735
15. Mueller-Koch Y., Vogelsang H., Kopp R., et al. Hereditary non-polyposis colorectal cancer: clinical and molecular evidence for a new entity of hereditary colorectal cancer. Gut 54 12 (2005) 1733-1740
16. Dove-Edwin I., De Jong A., Adams J., et al. Prospective results of surveillance colonoscopy in dominant familial colorectal cancer with and without Lynch syndrome. Gastroenterology 130 (2006) 1995-2000
17. Valle L., Perea J., Carbonell P., et al. Clinicopathologic and pedigree differences in Amsterdam-I-positive hereditary nonpolyposis colorectal cancer families according to tumor microsatellite instability status. J Clin Oncol 25 7 (2007) 781-786
18. Llor X., Pons E., Xicola R., et al. Differential features of colorectal cancers fulfilling Amsterdam Criteria without involvement of the mutation pathway. Clin Cancer Res 11 20 (2005) 7304-7310
19. Jenkins M., Croitoru M., Monga N., et al. Risk of colorectal cancer in monoallelic and biallelic carriers of MYH mutations: a population-based case-family study. Cancer Epidemiol Biomarkers Prev 15 2 (2006) 312-314
20. Minoo P., Baker K., Goswami R., et al. Extensive DNA methylation in normal colorectal mucosa in hyperplastic polyposis. Gut 55 10 (2006) 1467-1474
21. Aaltonen L., Johns L., Jarvinen H., et al. Explaining the familial colorectal cancer risk associated with mismatch repair (MMR)-deficient and MMR-stable tumors. Clin Cancer Res 13 1 (2007) 356-361
22. Hendriks Y., deJong A., Morreaqu H., et al. Diagnostic approach and management of Lynch syndrome (hereditary nonpolyposis colorectal carcinoma): a guide for clinicians. CA Cancer J Clin 56 (2006) 213-225